tiprankstipranks
Advertisement
Advertisement

Synergy CHC Brand License Terminated, Eyes Direct Expansion

Story Highlights
  • Synergy CHC’s exclusive UAE and Turkey license deal with Gravity, signed in 2025 for $2.9 million, was terminated ab initio on February 27, 2026.
  • Despite losing Gravity as a licensee, Synergy CHC continues pursuing registration and marketing of FOCUSfactor and Flat Tummy Co. in the UAE and Turkish markets.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Synergy CHC Brand License Terminated, Eyes Direct Expansion

Claim 55% Off TipRanks

Synergy CHC ( (SNYR) ) has shared an update.

On February 27, 2026, Synergy CHC Corp. was informed by Gravity Pharma General Trading LLC that Gravity was terminating from inception their Brand License Agreement, originally signed on March 31, 2025 and amended June 30, 2025, which had granted Gravity exclusive rights to sell and market FOCUSfactor and Flat Tummy Co. products in the United Arab Emirates and Turkey for a $2.9 million license fee that Synergy had previously recognized as revenue. Despite the termination of this exclusive arrangement, Synergy is continuing to pursue registration and marketing of these brands in the affected territories, indicating that the company still views the UAE and Turkish markets as strategically important for its international growth plans and brand presence.

The most recent analyst rating on (SNYR) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Synergy CHC stock, see the SNYR Stock Forecast page.

Spark’s Take on SNYR Stock

According to Spark, TipRanks’ AI Analyst, SNYR is a Neutral.

The score is held back primarily by balance sheet stress (negative equity) and negative recent cash generation, which elevate financing risk despite improved profitability. Technical indicators also point to weak momentum below major moving averages. These are partially offset by a low P/E valuation and an earnings call that showed revenue growth and margin improvement but weaker net income/EPS and higher operating cash usage.

To see Spark’s full report on SNYR stock, click here.

More about Synergy CHC

Synergy CHC Corp. operates in the consumer health and wellness sector, marketing brands such as FOCUSfactor, a cognitive health supplement line, and Flat Tummy Co., which targets weight management and lifestyle-conscious consumers. The company focuses on expanding the geographic reach and brand recognition of these products through licensing and regional marketing arrangements.

Average Trading Volume: 27,839

Technical Sentiment Signal: Sell

Current Market Cap: $15.64M

Learn more about SNYR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1